NSA urged the FDA to act on the recent findings of its scientific panel and recommended further study of PPA and its relation to stroke. The FDA's actions were based on a report stating that PPA should not be classified as safe and may increase the risk of hemorrhagic stroke in people, primarily women, under the age of 50. The drug constricts blood vessels and may seriously raise a person's blood pressure, which could cause a hemorrhage.
Stroke is a misunderstood, life-threatening medical condition.
Dr. Brass conducted this study during the past nine years. Dr. Brass and other medical experts are available for interviews. Nearly 750,000 Americans suffer strokes each year with one occurring every 45 seconds and a death resulting from stroke every 3 minutes. Based in Englewood, Colorado, National Stroke Association is the leading non-profit organization devoting 100 percent of its efforts and resources to stroke prevention, acute treatment, and support for families and caregivers.